-
Pharma and Biotech Layoffs Signal Strategic Shift Towards Efficiency Amid Industry Restructuring
05 Nov 2024 06:40 GMT
… pressure. Shattuck Labs’ layoffs and pipeline adjustments suggest … reductions. For example, Astellas closed its South San … to Financial Underperformance
Some layoffs, particularly in the CRO … Broader Industry Implications
The layoffs across the sector reflect …
-
Fierce Pharma Asia—Astellas' first-in-class FDA nod; Otsuka's IgAN win; Samsung Bio's $1.2B contract
25 Oct 2024 19:58 GMT
… customer to date.
1. Astellas nabs class-first FDA approval … After a prior rejection, Astellas has picked up an FDA … Takeda details another round of layoffs in Massachusetts as restructuring drive … to Massachusetts that it will lay off 79 employees across two …
-
Biopharma Giants Face Industry-Wide Layoffs Amid Economic Pressures
01 Oct 2024 13:58 GMT
… healthcare landscape .
Astellas (September 4, 2024)
Astellas Gene Therapies … September 5, 2024)
ImmunityBio laid off 16% of its workforce as … , announced it will lay off 650 employees as part … organization (CDMO), announced layoffs affecting 95 employees, as …
-
Astellas Gene Therapies to turn out the lights at South San Francisco production plant
04 Sep 2024 21:22 GMT
… The first tranche of layoffs affecting 10 employees took … the second notice states.
Astellas Gene Therapies’ manufacturing … partners’ needs.”
While Astellas’ gene therapy manufacturing … Area businesses, including Astellas Gene Therapies, Xyphos Biosciences …
-
Biopharma Layoff Tracker 2023: Aclaris, Asher, Atara and More Cut Staff
06 Jan 2023 00:00 GMT
… therapy biotech Atsena Therapeutics recently laid off an undisclosed number of employees … is also facing competition from Astellas, whose eye therapy Izervay was … site and lay off 113 employees.
Sangamo Therapeutics announced plans to layoff about …
-
Sumitomo brings together Gemtesa 'Go-Getters' to discuss overactive bladder symptoms
04 Dec 2024 19:16 GMT
… drivers at the company, which laid off 400 staffers earlier this year … grow after generic copies of Astellas’ rival OAB medicine Myrbetriq came …
-
BLCM Plunges On Clinical Hold, Elite On Watch, VICL To Lay Off 54% Of Staff
31 Jan 2018 06:24 GMT
Today's Daily Dose brings you news about Avinger's reverse stock split; FDA clinical hold on Bellicum's BPX-501 trials; Elite's progress with SequestOx and Vical's restructuring.
Read on…
Avinger Inc. (AVGR) has implemented a 1-for-40 …
-
Q3 Biotech Earnings Recap: Nkarta, Intellia, Cassava and more
12 Nov 2024 15:21 GMT
… failure of HIL-214, HilleVax laid off 41 employees, or 40% of … program under its collaboration with Astellas subsidiary Xyphos Biosciences. The two …
-
Gene editing sector investment struggles: What’s driving the slowdown?
11 Nov 2024 17:20 GMT
… to make major layoffs in order to survive.
Layoffs at Tome … technology, had instituted widespread layoffs and is scaling back its … established bluebird bio had to lay off 25% of its workforce … option and license agreement with Astellas for its gene therapy …
-
Top 10 U.S. biopharma hubs of 2024: East Coast dominance continues
07 Nov 2024 06:36 GMT
… region has seen significant biopharma layoffs, there have also been positive … the NIH in 2024. Additionally, Astellas opened a new $90 million … , for instance, announced plans to lay off 863 employees in Lawrenceville, New …